Novel Extensions of Alcohol Contingency Management in People Living with HIV

艾滋病毒感染者酒精应急管理的新扩展

基本信息

  • 批准号:
    10304325
  • 负责人:
  • 金额:
    $ 44.69万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-10 至 2026-08-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY Alcohol misuse in people living with HIV (PLWH) is a public health issue given relationships to cognitive and physical effects, which may subsequently accelerate HIV progression, increase likelihood of transmission and hasten related comorbidities. Thus, efficacious interventions to reduce alcohol use in PLWH are needed. Specifically, contingency management (CM; tangible reinforcement to change behavior) has been efficacious for alcohol intervention in the general population, but there are no published studies focused on testing CM for alcohol misuse in PLWH. Our current project testing 30-day CM including a subsample of PLWH (U01 AA020797) has promising preliminary findings. Despite its efficacy, remaining concerns about CM typically relate to long-term feasibility given financial costs or the possibility that negative behaviors will return when reinforcement ends. Thus, there is a need for approaches to extend CM beyond a limited period and make this approach amenable to wide dissemination. In this proposed P01 component project (N=120), we will implement several innovations to address feasibility concerns with an eye to research using implementation science methods in community health centers and clinics. Our novel approach will marshal mobile health (mHealth) capabilities, alcohol biosensors and gamification, which may enhance engagement through social connections and friendly competition. We will extend our current CM research by enrolling a wider range of participants regarding drinking behavior, age and comorbidities in a 30-day CM induction period. Bio- confirmation will be based on smartphone breath alcohol readings with identity confirmation. Our findings indicate the majority of PLWH avoid heavy drinking for at least 30 days with CM but a considerable minority do not, making prediction of outcome based on key baseline characteristics important. After 30 days, participants will be engaged in a motivational interview (MI) including personalized feedback based on reductions in alcohol use, enhanced cognitive and/or physical functioning. Following the 30-day CM induction and MI, responders will be randomized to 1 of 3 conditions to inform progress toward disseminable CM: 1) CM with intermittent reinforcement, plus novel, mHealth-based gamification; 2) CM with intermittent reinforcement without gamification; 3) or non-contingent reinforcement (control condition). In this innovative, second 30-day period, reinforcement will be based on wrist biosensor not breath alcohol readings and on a weekly rather than daily basis including reinforcement for bio-confirmed drinking moderation, not only abstinence. Follow-up will occur at 60, 90 and 180 days. Primary aims will test the magnitude of increases in percent days abstinent during the 30-day CM induction and baseline predictors of outcome (e.g., drinking severity, executive function). We will also test alcohol abstinence as a predictor of cognitive, biological and HIV outcomes. In addition, we will compare acceptability and preliminary efficacy across the 3 study conditions during the second, 30-day CM period. This project is an initial step to implement affordable, technology-based CM for alcohol in PLWH.
项目总结 艾滋病毒携带者(PLWH)的酒精滥用是一个公共卫生问题,因为它与认知和 物理效应,这可能随后加速艾滋病毒的进展,增加传播和 加速相关的合并症。因此,需要采取有效的干预措施来减少PLWH患者的酒精使用。 具体来说,应急管理(CM;改变行为的有形强化)一直是有效的 在一般人群中进行酒精干预,但还没有发表的研究集中于测试CM PLWH中的酒精滥用。我们当前的项目测试30天CM,包括PLWH(U01)的一个子样本 AA020797)有很有希望的初步发现。尽管CM有效,但人们对CM的担忧通常 与长期可行性有关,考虑到财务成本,或负面行为在以下情况下重新出现的可能性 加固结束。因此,需要一种方法来将CM扩展到有限的期限之外,并使其 可广泛传播的方法。在这个拟议的P01组件项目(N=120)中,我们将 实施几项创新,以解决可行性问题,并着眼于使用实施进行研究 社区卫生中心和诊所的科学方法。我们的新方法将引领移动医疗 (MHealth)能力、酒精生物传感器和游戏化,这可能会通过社交提高参与度 人脉和友好竞争。我们将扩大我们目前的CM研究,招募更广泛的 在为期30天的CM诱导期内,参与者关于饮酒行为、年龄和合并症的情况。生物- 确认将基于智能手机呼气酒精读数和身份确认。我们的发现 表明大多数PLWH在服用CM后至少30天内避免大量饮酒,但相当一部分人这样做 不是,这使得基于关键基线特征的结果预测变得重要。30天后,参与者 将参加激励性面试(MI),包括基于减少饮酒的个性化反馈 使用,增强认知和/或身体功能。在30天的CM诱导和MI之后,应答者 将随机分为3种情况之一,以告知可传播CM的进展情况:1)CM间歇性 强化,外加新颖的基于mHealth的游戏化;2)无间歇性强化的CM 游戏化;3)或非偶然强化(控制条件)。在这个创新的,第二个30天的时间里, 加强将基于手腕生物传感器,而不是呼吸酒精读数和每周而不是每天 基础包括加强生物确认的饮酒节制,而不仅仅是禁欲。将会有后续行动 60天、90天和180天。主要目标将测试戒酒天数百分比的增加幅度 30天CM诱导和基线结果预测因素(例如,饮酒严重程度、执行功能)。我们会 也要测试戒酒作为认知、生物学和艾滋病毒结果的预测指标。此外,我们还将 在第二次、30天的CM中,比较3种研究条件的可接受性和初步疗效 句号。该项目是在PLWH实施负担得起的、基于技术的酒精CM的第一步。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ROBERT F LEEMAN其他文献

ROBERT F LEEMAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ROBERT F LEEMAN', 18)}}的其他基金

Development and Initial Testing of a Multi-Component Breath Alcohol-Focused Intervention for Young Adults
针对年轻人的多成分呼吸酒精干预措施的开发和初步测试
  • 批准号:
    10755467
  • 财政年份:
    2023
  • 资助金额:
    $ 44.69万
  • 项目类别:
Linking Impulsivity Domains and Subjective Response to Alcohol in Young Adults Using Lab and Daily Assessment Methods
使用实验室和日常评估方法将年轻人的冲动域和对酒精的主观反应联系起来
  • 批准号:
    10453125
  • 财政年份:
    2022
  • 资助金额:
    $ 44.69万
  • 项目类别:
Linking Impulsivity Domains and Subjective Response to Alcohol in Young Adults Using Lab and Daily Assessment Methods
使用实验室和日常评估方法将年轻人的冲动域和对酒精的主观反应联系起来
  • 批准号:
    10706464
  • 财政年份:
    2022
  • 资助金额:
    $ 44.69万
  • 项目类别:
Novel Extensions of Alcohol Contingency Management in People Living with HIV
艾滋病毒感染者酒精应急管理的新扩展
  • 批准号:
    10682456
  • 财政年份:
    2021
  • 资助金额:
    $ 44.69万
  • 项目类别:
Mobile Combined Alcohol and HIV Prevention Including PrEP Uptake/Adherence for High-Risk Young Men
移动酒精和艾滋病毒联合预防,包括高危年轻男性的 PrEP 摄取/坚持
  • 批准号:
    10242805
  • 财政年份:
    2017
  • 资助金额:
    $ 44.69万
  • 项目类别:
Mobile Combined Alcohol and HIV Prevention Including PrEP Uptake/Adherence for High-Risk Young Men
移动酒精和艾滋病毒联合预防,包括高危年轻男性的 PrEP 摄取/坚持
  • 批准号:
    10840225
  • 财政年份:
    2017
  • 资助金额:
    $ 44.69万
  • 项目类别:
Mobile Combined Alcohol and HIV Prevention Including PrEP Uptake/Adherence for High-Risk Young Men
移动酒精和艾滋病毒联合预防,包括高危年轻男性的 PrEP 摄取/坚持
  • 批准号:
    10020295
  • 财政年份:
    2017
  • 资助金额:
    $ 44.69万
  • 项目类别:
Mobile Combined Alcohol and HIV Prevention Including PrEP Uptake/Adherence for High-Risk Young Men
移动酒精和艾滋病毒联合预防,包括高危年轻男性的 PrEP 摄取/坚持
  • 批准号:
    9564824
  • 财政年份:
    2017
  • 资助金额:
    $ 44.69万
  • 项目类别:
Testing a Smartphone Breathalyzer and BAC Estimator in Young Adult Heavy Drinkers
在年轻成年酗酒者中测试智能手机呼气分析仪和 BAC 估算器
  • 批准号:
    9282848
  • 财政年份:
    2016
  • 资助金额:
    $ 44.69万
  • 项目类别:
Testing a Smartphone Breathalyzer and BAC Estimator in Young Adult Heavy Drinkers
在年轻成年酗酒者中测试智能手机呼气分析仪和 BAC 估算器
  • 批准号:
    9212072
  • 财政年份:
    2016
  • 资助金额:
    $ 44.69万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 44.69万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 44.69万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 44.69万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 44.69万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 44.69万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 44.69万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 44.69万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 44.69万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 44.69万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 44.69万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了